Clinical trial Recruiting at 1 site Observational Ages 6 Months to 17

Trying ViBandz for children with neurologic movement problems

Official title: ViBandz Feasibility Study in the Neurological Pediatric Population

Run by Children's Mercy Hospital Kansas City · NCT07458568 · Data updated 2026-11-12

We will try the ViBandz vibration device with children aged 6 months to 17 years who have neurologic movement problems during their regular PT/OT clinic visit.

Quick facts

Study typeObservational
Ages6 Months to 17 Years
SexAll
Enrollment30 (estimated)
SponsorChildren's Mercy Hospital Kansas City
Academic / other
Locations1 site (Kansas City, Missouri)
StatusRecruiting
StartedApril 7, 2026
Main results expectedOctober 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 27, 2026
Trial IDNCT07458568 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6 months to 17 years with neurologic conditions causing abnormal movement of at least one extremity who have a scheduled PT/OT clinic visit including targeted focal vibration and whose parent or LAR speaks English are ideal candidates.

Probably not a fit

Children who are wards of the state, whose parent or LAR is not English-speaking, or who are not scheduled for targeted focal vibration in the CM PT/OT clinic are excluded and therefore unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-site feasibility project will test the ViBandz wearable vibration device with children who receive targeted focal vibration as part of their routine physical or occupational therapy at a Midwest pediatric tertiary care hospital. The design uses a mixed-methods approach with quantitative parent surveys completed immediately in clinic (or by email afterward) and secondary qualitative review of audio and optional video recorded during device use. All participants will receive their standard clinical targeted vibration first and then complete use of the ViBandz after their visit. The collected data will focus on feasibility, usability, and contextual feedback to guide future larger trials.

Why it matters

Potential benefit: If successful, ViBandz could provide a simple adjunct vibration tool to support targeted therapy for improving extremity movement in children with neurologic conditions.

How similar studies have gone: Targeted focal vibration has shown promising results in small pediatric and adult studies, but ViBandz as a specific device is novel and has limited prior clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (Children):

* Children of ages 6 months to 17 years old
* Neurologic conditions resulting in abnormal movement of at least one extremity
* Appointment scheduled in CM PT/OT clinic that would include targeted focal vibration as a standard of care

Exclusion Criteria (Children):

* Wards of the state

Inclusion Criteria (Parent/LAR):

* Parent or Legally Authorized Representative of a child with inclusion criteria above
* English-speaking

Exclusion Criteria (Parent/LAR):

* Non-English speaking

Where it's running

  • Children's Mercy Hospital
    Kansas City, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.